Vaxart, Inc.'s Q2 2024 business update conference call begins at 4:30 p.m. ET today. Listen here: https://bit.ly/4dlf3gO #PillThatMovesTheNeedle #vaccines #GlobalHealth
Vaxart, Inc.
Biotechnology Research
South San Francisco, California 8,316 followers
The pill that moves the needle.
About us
For two hundred years vaccines have been administered by intramuscular injection. Vaxart’s oral vaccine pills may change everything. Our vaccine pills act differently, by attacking invading pathogens in the places where they first enter the body: the mucosal areas, including the mouth, the nose and the gut. They are designed to trigger strong IgA and T-cell responses to repel and overwhelm the invading viral invaders. Vaxart has begun Phase II trials of its oral vaccine for Covid and for Norovirus– the only company in the world to reach this stage with a COVID-19 vaccine pill.
- Website
-
https://vaxart.com
External link for Vaxart, Inc.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- South San Francisco, California
- Type
- Public Company
- Founded
- 2004
- Specialties
- Biotechnology and Vaccines
Locations
-
Primary
290 Utah Ave
South San Francisco, California 94080, US
-
395 Oyster Point Blvd
South San Francisco, California 94080, US
Employees at Vaxart, Inc.
Updates
-
Vaxart, Inc. today announced its Q2 2024 business update. The Company achieved meaningful progress on its goals during the first half of 2024, most significantly with its BARDA contract for its COVID-19 program under Project NextGen. https://bit.ly/4dilams #PillThatMovesTheNeedle #Vaxart #COVID19
-
From Endpoints: The U.S. Treasury has committed $667 million for a global Pandemic Fund, but Congress still must sign off. https://bit.ly/46tz5DN Vaxart is working to bring a potentially transformational approach to confronting future pandemics. #PillThatMovesTheNeedle #Vaxart #pandemicpreparedness
US bankrolls a third of global Pandemic Fund. Can it get congressional support?
endpts.com
-
COVID is not going away. A Los Angeles Times article highlights a recent surge of #COVID19 cases in California. To address public health threats, Vaxart continues its work to develop a next generation oral pill COVID-19 vaccine. https://lnkd.in/eGr9xyie #PillThatMovesTheNeedle
COVID surging in California, nears two-year summer high. 'Almost everybody has it'
latimes.com
-
From Nature Magazine: Bird flu could become a human pandemic. How are countries preparing? https://lnkd.in/e_bvx4p5 Vaxart believes mucosal immunity is critical, as it may provide protection against pathogens that enter at a mucosal surface. #PillThatMovesTheNeedle #Vaxart #publichealth
Bird flu could become a human pandemic. How are countries preparing?
nature.com
-
Axios reports that COVID-19 cases are growing or likely growing in 45 states and territories. https://bit.ly/3Y7eYJd Vaxart believes its investigational oral pill vaccine platform can better meet societal needs for many infectious disease pandemic and endemic threats. #PillThatMovesTheNeedle #Vaxart #COVID19 #pandemicpreparedness
Mapped: Another hot COVID summer
axios.com
-
From Axios: Global battle to reach millions of children missing out on vaccination. https://bit.ly/464a01Z Vaxart’s oral norovirus vaccine candidate is in clinical trials to test if it could help nursing mothers vaccinate and protect this vulnerable population. #PillThatMovesTheNeedle #Vaxart #norovirus
Kids' vaccination stalls globally, WHO finds
axios.com
-
From Tina Reed and Adriel Bettelheim of Axios: Kids' vaccination stalls globally, WHO finds, leaving 2.7 million more kids lacking protection they need. https://bit.ly/464a01Z Vaxart polling has shown a pill option may help us vaccinate more people. #PillThatMovesTheNeedle #Vaxart #vaccines
Kids' vaccination stalls globally, WHO finds
axios.com
-
BARDA on working with Vaxart: “We look at every investment we make as a true partnership, where we’re working with the company to help give them the best chance of success to move those products forward.” https://bit.ly/3zioZsC #PillThatMovesTheNeedle #Vaxart #BARDA #COVID19
Inside BARDA’s multibillion-dollar effort to fund long-shot biotechs for Covid
https://endpts.com
-
Vaxart Chief Scientific Officer Dr. Sean Tucker on testing for asymptomatic infection: “It’s an incredible expense, and we’re grateful.” The testing investment reflects BARDA’s aspirations for Project NextGen-funded trials. https://bit.ly/3zioZsC #PillThatMovesTheNeedle #Vaxart #COVID19 #BARDA
Inside BARDA’s multibillion-dollar effort to fund long-shot biotechs for Covid
https://endpts.com